Navigation Links
Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training
Date:10/14/2009

SCOTTSDALE, Ariz., Oct. 14 /PRNewswire/ -- When it comes to slumping profitability in the current pharmaceutical sales industry, it is easy to point a finger at a shrinking sales force, the economic downturn and strict government regulations. But new data from the 2009 Leadership Skills Survey, conducted by pharmaceutical consulting firm DELTA POINT, Inc. (http://www.gottochange.com), indicates that the root of the problem actually rests with the productivity of sales associates. More importantly, their productivity directly depends on the robust training of selling and relationship-building skills of new and seasoned managers alike. According to the survey results, without such development, managers cannot properly empower sales associates to meet and exceed their goals.

"Through the 2009 Leadership Skills Survey, we discovered that the success of a pharmaceutical sales rep is determined by this person's ability to foster meaningful customer relationships and create beneficial dialogue with customers -- which then generates results," says Jerry Acuff, DELTA POINT's CEO. "Yet all this stems from the manager's abilities as a skilled leader and trainer. In fact, over 90 percent of our survey respondents said it is the manager's responsibility to improve the sales representative's skills."

Specifically, the 2009 Leadership Skills Survey explored the training needs of sales associates and their managers. Various professionals within the pharmaceutical industry completed the surveys -- from district sales managers to marketing directors to vice presidents. The pool of respondents represented 20 different pharmaceutical companies, including eight of the top 10 pharmaceutical companies nationwide. Officially released this week, the study's key findings include:

  • Over 90 percent of respondents believe it is the manager's responsibility to assist the sales reps in building customer connections.
  • Approximately two-thirds of respondents think their companies don't provide adequate training around sales skills and relationship building for managers.
  • A significant gap exists between the importance placed on skills that enhance customer relationships and the training structure and opportunities that pharmaceutical companies are currently providing managers.

Despite the need for stronger managerial training, as well as greater education among the sales force, only 32 percent of respondents indicated that their companies offer a formalized program for improving sales skills. Meanwhile, a mere 34 percent receive training that is dedicated to the specific concerns related to improving customer relationships, and particularly those of a more challenging nature.

For more information about the 2009 Leadership Skills Survey, email jacuff@gottochange.com.

About DELTA POINT, Inc.

As a consulting company that works mostly with pharmaceutical companies, DELTA POINT focuses on improving outcomes to help brands that are facing challenges whether it is launching a new product, underperforming due to a noisy marketplace and/or facing stiff competition, or having difficulties in communicating the brand message. DELTA POINT works with marketing, sales management, sales training and sales operations as a partner in attaining business success through improving sales messaging and providing its clients with a proven method of building, sustaining and growing substantive business relationships.

    Contact:

    Jerry Acuff
    DELTA POINT, Inc.
    480-296-9972
    E-mail: jacuff@gottochange.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE DELTA POINT, Inc.


'/>"/>
SOURCE DELTA POINT, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executives Employment Agreement
2. VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ
3. The Governator and the Disintegrator: A Sharp Match Holding Pharmaceutical Companies Accountable
4. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
5. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
6. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
7. Onyx Pharmaceuticals to Acquire Proteolix, Inc.
8. Onyx Pharmaceuticals Announces Investor Teleconference and Webcast
9. ADVENTRX Pharmaceuticals Announces Closing of Financing
10. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
11. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Nov. 29, 2016 Several leading Alzheimer,s ... Accera, Inc. at 11 a.m. EST on ... Conference on Clinical Trials for Alzheimer,s Disease (CTAD). The ... in Alzheimer,s disease and therapeutic targets that address deficient ... "Following the recent failure of another therapy targeting the ...
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. 5, ... Commercialization of Public Research (the Florida Institute) ... agreement SegAna, LLC, an Orlando ... Central Florida. The Florida Institute supports new company ... funding gaps for companies spinning out of Florida-based universities ...
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ Cartilage ... Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - Forecast ... USD 779.8 Million by 2021 from USD 414.6 Million in 2016, ... 2016 to 2021. Continue Reading ... ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health ... Distinction, recognizing the organization as a top behavioral service provider in the country. ... clinical quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are measured ...
(Date:12/6/2016)... ... December 06, 2016 , ... Experimentation ... research and development, largely due to its potential for revolutionizing human disease treatment. ... and human induced pluripotent stem cells (hiPSCs). , Both platforms have distinct ...
(Date:12/6/2016)... ... December 06, 2016 , ... METTLER TOLEDO has ... knowledge resources, including white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, ... more than 9,000 documents, webinars and videos available online, visit the METTLER ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit ... EHS audit protocols to understand the scope of their EHS regulatory obligations and ...
Breaking Medicine News(10 mins):